Risk factors

Solid Biosciences (SLDB) risk factors

Item 1A of every Solid Biosciences Inc. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.

Open SLDB in Gloom →
Solid Biosciences' chart, financials and news, free in your browser.Open SLDB in Gloom →
  • FY2025 10-K risk factors
    107 risks10 new2 dropped21 reworded

    Trade-policy changes could impose tariffs on imported pharmaceuticals and ingredients, including a threatened 100% tariff on branded or patented drugs.

    Filed Mar 19, 2026
  • FY2024 10-K risk factors
    99 risks

    Solid Biosciences faces ongoing operating losses, accumulating $783.5 million through December 31, 2024, and needs additional capital.

    Filed Mar 06, 2025